메뉴 건너뛰기




Volumn 18, Issue 13, 2012, Pages 3648-3657

Serum sex steroids depict a nonlinear U-shaped association with high-risk prostate cancer at radical prostatectomy

Author keywords

[No Author keywords available]

Indexed keywords

ESTRADIOL; SEX HORMONE BINDING PROTEIN; TESTOSTERONE;

EID: 84863326885     PISSN: 10780432     EISSN: 15573265     Source Type: Journal    
DOI: 10.1158/1078-0432.CCR-11-2799     Document Type: Article
Times cited : (61)

References (50)
  • 1
    • 39149084101 scopus 로고    scopus 로고
    • Endogenous sex hormones and prostate cancer: A collaborative analysis of 18 prospective studies
    • Endogenous Hormones and Prostate Cancer Collaborative Group
    • Endogenous Hormones and Prostate Cancer Collaborative Group RoddamAW, Allen NE, Appleby P, Key TJ. Endogenous sex hormones and prostate cancer: a collaborative analysis of 18 prospective studies. J Natl Cancer Inst 2008;100:170-83.
    • (2008) J Natl Cancer Inst , vol.100 , pp. 170-183
    • Roddam, A.W.1    Allen, N.E.2    Appleby, P.3    Key, T.J.4
  • 2
    • 57649176913 scopus 로고    scopus 로고
    • Shifting the paradigm of testosterone and prostate cancer: The saturation model and the limits of androgen-dependent growth
    • Morgentaler A, Traish AM. Shifting the paradigm of testosterone and prostate cancer: the saturation model and the limits of androgen-dependent growth. Eur Urol 2009;55:310-20.
    • (2009) Eur Urol , vol.55 , pp. 310-320
    • Morgentaler, A.1    Traish, A.M.2
  • 3
    • 33644601865 scopus 로고    scopus 로고
    • Low age adjusted free testosterone levels correlate with poorly differentiated prostate cancer
    • San Francisco IF, Regan MM, Dewolf WC, Olumi AF. Low age adjusted free testosterone levels correlate with poorly differentiated prostate cancer. J Urol 2006;175:1341-5.
    • (2006) J Urol , vol.175 , pp. 1341-1345
    • San Francisco, I.F.1    Regan, M.M.2    Dewolf, W.C.3    Olumi, A.F.4
  • 4
    • 41749098807 scopus 로고    scopus 로고
    • The ratio of serum testosterone to prostate specific antigen predicts prostate cancer in hypogonadal men
    • Rhoden EL, Riedner CL, Morgentaler A. The ratio of serum testosterone to prostate specific antigen predicts prostate cancer in hypogonadal men. J Urol 2008;179:1741-5.
    • (2008) J Urol , vol.179 , pp. 1741-1745
    • Rhoden, E.L.1    Riedner, C.L.2    Morgentaler, A.3
  • 5
    • 27744467589 scopus 로고    scopus 로고
    • Low serum testosterone levels are associated with positive surgical margins in radical retropubic prostatectomy: Hypogonadism represents bad prognosis in prostate cancer
    • DOI 10.1097/01.ju.0000181818.51977.29
    • Teloken C, Da Ros CT, Caraver F, Weber FA, Cavalheiro AP, Graziottin TM. Low serum testosterone levels are associated with positive surgical margins in radical retropubic prostatectomy: hypogonadism represents bad prognosis in prostate cancer. J Urol 2005;174:2178-80. (Pubitemid 41611769)
    • (2005) Journal of Urology , vol.174 , Issue.6 , pp. 2178-2180
    • Teloken, C.1    Teodosio, D.R.C.2    Caraver, F.3    Weber, F.A.4    Cavalheiro, A.P.5    Graziottin, T.M.6
  • 7
    • 13844299328 scopus 로고    scopus 로고
    • Pretreatment serum testosterone level as a predictive factor of pathological stage in localized prostate cancer patients treated with radical prostatectomy
    • DOI 10.1016/j.eururo.2004.11.003
    • Imamoto T, Suzuki H, Fukasawa S, Shimbo M, Inahara M, Komiya A, et al. Pretreatment serum testosterone level as a predictive factor of pathological stage in localized prostate cancer patients treated with radical prostatectomy. Eur Urol 2005;47:308-12. (Pubitemid 40248848)
    • (2005) European Urology , vol.47 , Issue.3 , pp. 308-312
    • Imamoto, T.1    Suzuki, H.2    Fukasawa, S.3    Shimbo, M.4    Inahara, M.5    Komiya, A.6    Ueda, T.7    Shiraishi, T.8    Ichikawa, T.9
  • 8
    • 18744369944 scopus 로고    scopus 로고
    • Testosterone as a predictor of pathological stage in clinically localized prostate cancer
    • DOI 10.1097/01.ju.0000158040.33531.e7
    • Isom-Batz G, Bianco FJ Jr, KattanMW,Mulhall JP, Lilja H, EasthamJA. Testosterone as a predictor of pathological stage in clinically localized prostate cancer. J Urol 2005;173:1935-7. (Pubitemid 40675215)
    • (2005) Journal of Urology , vol.173 , Issue.6 , pp. 1935-1937
    • Isom-Batz, G.1    Blanco Jr., F.J.2    Kattan, M.W.3    Mulhall, J.P.4    Lilja, H.5    Eastham, J.A.6
  • 9
    • 77649247662 scopus 로고    scopus 로고
    • Serum testosterone is associated with aggressive prostate cancer in older men: Results from the Baltimore Longitudinal Study of Aging
    • Pierorazio PM, Ferrucci L, Kettermann A, Longo DL, Metter EJ, Carter HB. Serum testosterone is associated with aggressive prostate cancer in older men: results from the Baltimore Longitudinal Study of Aging. BJU Int 2010;105:824-9.
    • (2010) BJU Int , vol.105 , pp. 824-829
    • Pierorazio, P.M.1    Ferrucci, L.2    Kettermann, A.3    Longo, D.L.4    Metter, E.J.5    Carter, H.B.6
  • 10
    • 34547156657 scopus 로고    scopus 로고
    • Preoperative Serum Testosterone Level as an Independent Predictor of Treatment Failure following Radical Prostatectomy
    • DOI 10.1016/j.eururo.2007.03.052, PII S0302283807004289
    • Yamamoto S, Yonese J, Kawakami S, Ohkubo Y, Tatokoro M, Komai Y, et al. Preoperative serum testosterone level as an independent predictor of treatment failure following radical prostatectomy. Eur Urol 2007;52:696-701. (Pubitemid 47126163)
    • (2007) European Urology , vol.52 , Issue.3 , pp. 696-701
    • Yamamoto, S.1    Yonese, J.2    Kawakami, S.3    Ohkubo, Y.4    Tatokoro, M.5    Komai, Y.6    Takeshita, H.7    Ishikawa, Y.8    Fukui, I.9
  • 11
    • 84857033892 scopus 로고    scopus 로고
    • Serum testosterone level as a predictor of biochemical failure after radical prostatectomy for localized prostate cancer
    • Røder MA, Christensen IJ, Berg KD, Gruschy L, Brasso K, Iversen P. Serum testosterone level as a predictor of biochemical failure after radical prostatectomy for localized prostate cancer. BJU Int 2012;109:520-4.
    • (2012) BJU Int , vol.109 , pp. 520-524
    • Røder, M.A.1    Christensen, I.J.2    Berg, K.D.3    Gruschy, L.4    Brasso, K.5    Iversen, P.6
  • 12
    • 3042760475 scopus 로고    scopus 로고
    • High level of androgen receptor is associated with aggressive clinicopathologic features and decreased biochemical recurrence-free survival in prostate: Cancer patients treated with radical prostatectomy
    • DOI 10.1097/00000478-200407000-00013
    • Li R, Wheeler T, Dai H, Frolov A, Thompson T, Ayala G. High level of androgen receptor is associated with aggressive clinicopathologic features and decreased biochemical recurrence-free survival in prostate: cancer patients treated with radical prostatectomy. Am J Surg Pathol 2004;28:928-34. (Pubitemid 38856850)
    • (2004) American Journal of Surgical Pathology , vol.28 , Issue.7 , pp. 928-934
    • Li, R.1    Wheeler, T.2    Dai, H.3    Frolov, A.4    Thompson, T.5    Ayala, G.6
  • 13
    • 0026021087 scopus 로고
    • Independent prognostic factors in patients with metastatic (stage D2) prostate cancer
    • for the Zoladex Study Group
    • Chodak GW, Vogelzang NJ, Caplan RJ, Soloway M, Smith JA for the Zoladex Study Group. Independent prognostic factors in patients with metastatic (stage D2) prostate cancer. JAMA 1991;265:618-21.
    • (1991) JAMA , vol.265 , pp. 618-621
    • Chodak, G.W.1    Vogelzang, N.J.2    Caplan, R.J.3    Soloway, M.4    Smith, J.A.5
  • 15
    • 48849111874 scopus 로고    scopus 로고
    • Development of a nomogram for predicting high-grade prostate cancer on biopsy: The significance of serum testosterone levels
    • Ide H, Yasuda M, Nishio K, Saito K, Isotani S, Kamiyama Y, et al. Development of a nomogram for predicting high-grade prostate cancer on biopsy: the significance of serum testosterone levels. Anticancer Res 2008;28:2487-92.
    • (2008) Anticancer Res , vol.28 , pp. 2487-2492
    • Ide, H.1    Yasuda, M.2    Nishio, K.3    Saito, K.4    Isotani, S.5    Kamiyama, Y.6
  • 17
    • 80052744918 scopus 로고    scopus 로고
    • High incidence of predominant Gleason pattern 4 localized prostate cancer is associated with low serum testosterone
    • Botto H, Neuzillet Y, Lebret T, Camparo P, Molinie V, Raynaud JP. High incidence of predominant Gleason pattern 4 localized prostate cancer is associated with low serum testosterone. J Urol 2011;186:1400-5.
    • (2011) J Urol , vol.186 , pp. 1400-1405
    • Botto, H.1    Neuzillet, Y.2    Lebret, T.3    Camparo, P.4    Molinie, V.5    Raynaud, J.P.6
  • 18
    • 79960258328 scopus 로고    scopus 로고
    • Preoperative hypogonadism is not an independent predictor of highrisk disease in patients undergoing radical prostatectomy
    • Salonia A, Gallina A, Briganti A, Abdollah F, Suardi N, Capitanio U, et al. Preoperative hypogonadism is not an independent predictor of highrisk disease in patients undergoing radical prostatectomy. Cancer 2011;117:3953-62.
    • (2011) Cancer , vol.117 , pp. 3953-3962
    • Salonia, A.1    Gallina, A.2    Briganti, A.3    Abdollah, F.4    Suardi, N.5    Capitanio, U.6
  • 20
    • 33847163949 scopus 로고    scopus 로고
    • The endocrine profiles in men with localized and locally advanced prostate cancer treated with radical prostatectomy
    • Heracek J, Urban M, Sachova J, Kuncova J, Eis V, Mandys V, et al. The endocrine profiles in men with localized and locally advanced prostate cancer treated with radical prostatectomy. Neuro Endocrinol Lett 2007;28:45-51. (Pubitemid 46291146)
    • (2007) Neuroendocrinology Letters , vol.28 , Issue.1 , pp. 45-51
    • Heracek, J.1    Urban, M.2    Sachova, J.3    Kuncova, J.4    Eis, V.5    Mandys, V.6    Hampl, R.7    Starka, L.8
  • 21
    • 58649101843 scopus 로고    scopus 로고
    • Absence of relationship between steroid hormone levels and prostate cancer tumor grade
    • Sher DJ, Mantzoros C, Jacobus S, Regan MM, Lee GS, Oh WK. Absence of relationship between steroid hormone levels and prostate cancer tumor grade. Urology 2009;73:356-61.
    • (2009) Urology , vol.73 , pp. 356-361
    • Sher, D.J.1    Mantzoros, C.2    Jacobus, S.3    Regan, M.M.4    Lee, G.S.5    Oh, W.K.6
  • 22
    • 58849083630 scopus 로고    scopus 로고
    • The evolving role of oestrogens and their receptors in the development and progression of prostate cancer
    • Bonkhoff H, Berges R. The evolving role of oestrogens and their receptors in the development and progression of prostate cancer. Eur Urol 2009;55:533-542.
    • (2009) Eur Urol , vol.55 , pp. 533-542
    • Bonkhoff, H.1    Berges, R.2
  • 23
    • 80054756183 scopus 로고    scopus 로고
    • Circulating estradiol, but not testosterone, is a significant predictor of high-grade prostate cancer in patients undergoing radical prostatectomy
    • Salonia A, Gallina A, Briganti A, Suardi N, Capitanio U, Abdollah F, et al. Circulating estradiol, but not testosterone, is a significant predictor of high-grade prostate cancer in patients undergoing radical prostatectomy. Cancer 2011;117:5029-38.
    • (2011) Cancer , vol.117 , pp. 5029-5038
    • Salonia, A.1    Gallina, A.2    Briganti, A.3    Suardi, N.4    Capitanio, U.5    Abdollah, F.6
  • 24
    • 79954498385 scopus 로고    scopus 로고
    • Sex hormone-binding globulin is a significant predictor of extracapsular extension in men undergoing radical prostatectomy
    • Salonia A, Gallina A, Briganti A, Suardi N, Capitanio U, Abdollah F, et al. Sex hormone-binding globulin is a significant predictor of extracapsular extension in men undergoing radical prostatectomy. BJU Int 2011;107:1243-9.
    • (2011) BJU Int , vol.107 , pp. 1243-1249
    • Salonia, A.1    Gallina, A.2    Briganti, A.3    Suardi, N.4    Capitanio, U.5    Abdollah, F.6
  • 25
    • 79952253824 scopus 로고    scopus 로고
    • EAU guidelines on prostate cancer. Part II: Treatment of advanced, relapsing, and castration-resistant prostate cancer
    • Mottet N, Bellmunt J, Bolla M, Joniau S, Mason M, Matveev V, et al. EAU guidelines on prostate cancer. Part II: Treatment of advanced, relapsing, and castration-resistant prostate cancer. Eur Urol 2011;59:572-83.
    • (2011) Eur Urol , vol.59 , pp. 572-583
    • Mottet, N.1    Bellmunt, J.2    Bolla, M.3    Joniau, S.4    Mason, M.5    Matveev, V.6
  • 26
    • 84863300695 scopus 로고    scopus 로고
    • National Comprehensive Cancer Network practice guidelines 2011
    • [cited 2011 Jul 23]. Available from
    • National Comprehensive Cancer Network practice guidelines 2011. Prostate cancer. [cited 2011 Jul 23]. Available from: http://www.nccn.org/professionals/ physician-gls/pdf/prostate.pdf.
    • Prostate Cancer
  • 28
    • 3042692259 scopus 로고    scopus 로고
    • American Association of Clinical Endocrinologists Medical Guidelines for clinical practice for the evaluation and treatment of hypogonadism in adult male patients - 2002 update. Medical guidelines for clinical practice for the evaluation and treatment of hypogonadism in adult male patients-2002 update
    • American Association of Clinical Endocrinologists
    • Petak SM, Nankin HR, Spark RF, Swerdloff RS, Rodriguez-Rigau LJ American Association of Clinical Endocrinologists. American Association of Clinical Endocrinologists Medical Guidelines for clinical practice for the evaluation and treatment of hypogonadism in adult male patients - 2002 update. Medical guidelines for clinical practice for the evaluation and treatment of hypogonadism in adult male patients-2002 update. Endocr Pract 2002;8:440-56.
    • (2002) Endocr Pract , vol.8 , pp. 440-456
    • Petak, S.M.1    Nankin, H.R.2    Spark, R.F.3    Swerdloff, R.S.4    Rodriguez-Rigau, L.J.5
  • 29
    • 56249088599 scopus 로고    scopus 로고
    • Investigation, treatment, and monitoring of Late-Onset Hypogonadism in Males: ISA, ISSAM, EAU, EAA, and ASA Recommendations
    • Wang C, Nieschlag E, Swerdloff R, Behre HM, Hellstrom WJ, Gooren LJ, et al. Investigation, treatment, and monitoring of Late-Onset Hypogonadism in Males: ISA, ISSAM, EAU, EAA, and ASA Recommendations. Eur Urol 2009;55:121-30.
    • (2009) Eur Urol , vol.55 , pp. 121-130
    • Wang, C.1    Nieschlag, E.2    Swerdloff, R.3    Behre, H.M.4    Hellstrom, W.J.5    Gooren, L.J.6
  • 30
    • 77950874403 scopus 로고    scopus 로고
    • Tutorial in biostatistics: Dose-response analyses using restricted cubic spline functions in public health research
    • Desquilbet L, Mariotti F. Tutorial in biostatistics: dose-response analyses using restricted cubic spline functions in public health research. Stat Med 2010;29:1037-57.
    • (2010) Stat Med , vol.29 , pp. 1037-1057
    • Desquilbet, L.1    Mariotti, F.2
  • 31
    • 0029020424 scopus 로고
    • Dose-response and trend analysis in epidemiology: Alternatives to categorical analysis
    • Greenland S. Dose-response and trend analysis in epidemiology: alternatives to categorical analysis. Epidemiology 1995;6:356-65.
    • (1995) Epidemiology , vol.6 , pp. 356-365
    • Greenland, S.1
  • 33
    • 77951642063 scopus 로고    scopus 로고
    • Characteristics of secondary, primary, and compensated hypogonadism in aging men: Evidence from the European Male Ageing Study
    • Tajar A, Forti G, O'Neill TW, Lee DM, Silman AJ, Finn JD, et al. Characteristics of secondary, primary, and compensated hypogonadism in aging men: evidence from the European Male Ageing Study. J Clin Endocrinol Metab 2010;95:1810-8.
    • (2010) J Clin Endocrinol Metab , vol.95 , pp. 1810-1818
    • Tajar, A.1    Forti, G.2    O'Neill, T.W.3    Lee, D.M.4    Silman, A.J.5    Finn, J.D.6
  • 34
    • 70349229310 scopus 로고    scopus 로고
    • Increased endogenous estrogen synthesis leads to the sequential induction of prostatic inflammation (prostatitis) and prostatic pre-malignancy
    • Ellem SJ, Wang H, Poutanen M, Risbridger GP. Increased endogenous estrogen synthesis leads to the sequential induction of prostatic inflammation (prostatitis) and prostatic pre-malignancy. Am J Pathol 2009;175:1187-99.
    • (2009) Am J Pathol , vol.175 , pp. 1187-1199
    • Ellem, S.J.1    Wang, H.2    Poutanen, M.3    Risbridger, G.P.4
  • 35
    • 77950363332 scopus 로고    scopus 로고
    • Aromatase and regulating the estrogen: Androgen ratio in the prostate gland
    • Ellem SJ, Risbridger GP. Aromatase and regulating the estrogen: androgen ratio in the prostate gland. J Steroid Biochem Mol Biol 2010;118:246-51.
    • (2010) J Steroid Biochem Mol Biol , vol.118 , pp. 246-251
    • Ellem, S.J.1    Risbridger, G.P.2
  • 36
    • 79951989027 scopus 로고    scopus 로고
    • Impact of age at diagnosis on prostate cancer treatment and survival
    • Bechis SK, Carroll PR, Cooperberg MR. Impact of age at diagnosis on prostate cancer treatment and survival. J Clin Oncol 2011;29:235-41.
    • (2011) J Clin Oncol , vol.29 , pp. 235-241
    • Bechis, S.K.1    Carroll, P.R.2    Cooperberg, M.R.3
  • 37
    • 80255140736 scopus 로고    scopus 로고
    • Older age predicts decreased metastasis and prostate cancer-specific death for men treated with radiation therapy: Meta-analysis of Radiation Therapy Oncology Group Trials
    • Hamstra DA, Bae K, Pilepich MV, Hanks GE, Grignon DJ, McGowan DG, et al. Older age predicts decreased metastasis and prostate cancer-specific death for men treated with radiation therapy: meta-analysis of Radiation Therapy Oncology Group Trials. Int J Radiat Oncol Biol Phys 2011;81:1293-301.
    • (2011) Int J Radiat Oncol Biol Phys , vol.81 , pp. 1293-1301
    • Hamstra, D.A.1    Bae, K.2    Pilepich, M.V.3    Hanks, G.E.4    Grignon, D.J.5    McGowan, D.G.6
  • 38
    • 34250745251 scopus 로고    scopus 로고
    • Obesity and Prostate Cancer: Epidemiology and Clinical Implications
    • DOI 10.1016/j.eururo.2007.04.069, PII S0302283807006641
    • Buschemeyer WC III, Freedland SJ. Obesity and prostate cancer: epidemiology and clinical implications. Eur Urol 2007;52:331-43. (Pubitemid 46963472)
    • (2007) European Urology , vol.52 , Issue.2 , pp. 331-343
    • Buschemeyer III, W.C.1    Freedland, S.J.2
  • 42
    • 33947363367 scopus 로고    scopus 로고
    • Tissue and serum levels of principal androgens in benign prostatic hyperplasia and prostate cancer
    • DOI 10.1016/j.steroids.2007.01.004, PII S0039128X07000293
    • Heracek J, Hampl R, Hill M, Starka L, Sachova J, Kuncova J, et al. Tissue and serum levels of principal androgens in benign prostatic hyperplasia and prostate cancer. Steroids 2007;72:375-80. (Pubitemid 46452717)
    • (2007) Steroids , vol.72 , Issue.4 , pp. 375-380
    • Heracek, J.1    Richard, H.2    Martin, H.3    Luboslav, S.4    Jana, S.5    Jitka, K.6    Vaclav, E.7    Michael, U.8    Vaclav, M.9
  • 44
    • 27644452640 scopus 로고    scopus 로고
    • Testosterone and dihydrotestosterone tissue levels in recurrent prostate cancer
    • DOI 10.1158/1078-0432.CCR-05-0525
    • Titus MA, Schell MJ, Lih FB, Tomer KB, Mohler JL. Testosterone and dihydrotestosterone tissue levels in recurrent prostate cancer. Clin Cancer Res 2005;11:4653-7. (Pubitemid 41557182)
    • (2005) Clinical Cancer Research , vol.11 , Issue.13 , pp. 4653-4657
    • Titus, M.A.1    Schell, M.J.2    Lih, F.B.3    Tomer, K.B.4    Mohler, J.L.5
  • 45
    • 80052846905 scopus 로고    scopus 로고
    • Potential prostate cancer drug target: Bioactivation of androstanediol by conversion to dihydrotestosterone
    • Mohler JL, TitusMA, Wilson EM. Potential prostate cancer drug target: bioactivation of androstanediol by conversion to dihydrotestosterone. Clin Cancer Res 2011;17:5844-9.
    • (2011) Clin Cancer Res , vol.17 , pp. 5844-5849
    • Mohler, J.L.1    Titus, M.A.2    Wilson, E.M.3
  • 47
    • 76749096777 scopus 로고    scopus 로고
    • Variability in the androgen response of prostate epithelium to 5alpha-reductase inhibition: Implications for prostate cancer chemoprevention
    • Mostaghel EA, Geng L, Holcomb I, Coleman IM, Lucas J, True LD, et al. Variability in the androgen response of prostate epithelium to 5alpha-reductase inhibition: implications for prostate cancer chemoprevention. Cancer Res 2010;70:1286-95.
    • (2010) Cancer Res , vol.70 , pp. 1286-1295
    • Mostaghel, E.A.1    Geng, L.2    Holcomb, I.3    Coleman, I.M.4    Lucas, J.5    True, L.D.6
  • 50
    • 84859108456 scopus 로고    scopus 로고
    • Dutasteride in localised prostate cancer management: The REDEEM randomised, double-blind, placebo-controlled trial
    • Fleshner NE, Lucia MS, Egerdie B, Aaron L, Eure G, Nandy I, et al. Dutasteride in localised prostate cancer management: the REDEEM randomised, double-blind, placebo-controlled trial. Lancet 2012;379:1103-11
    • (2012) Lancet , vol.379 , pp. 1103-1111
    • Fleshner, N.E.1    Lucia, M.S.2    Egerdie, B.3    Aaron, L.4    Eure, G.5    Nandy, I.6


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.